103 results
Page 2 of 6
8-K
kz7mvm
25 Jul 22
Entry into a Material Definitive Agreement
8:00am
8-K
4eq7l o71
14 Jul 22
Entry into a Material Definitive Agreement
9:00am
SC TO-T
EX-99
tk9zqjk076
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-99.1
096k1vj5rkg
20 May 22
Regulation FD Disclosure
10:30am
8-K
EX-99.1
6yz01v
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.2
c5bm5ntfi4lhx0gz
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
lfs7h6 tvjvha4mkj
14 Apr 22
TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million
4:25pm
POS AM
787 q4v7v
23 Mar 22
Prospectus update (post-effective amendment)
6:06pm
POSASR
e6q5998oyss24ev
23 Mar 22
Automatic shelf registration (post-effective amendment)
4:37pm
8-K
EX-99.2
5av1un6ou votyw
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
hz0ryf6p35xuq7h6w ky
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
bllix4evifr6slcbj48
7 Mar 22
TherapeuticsMD Enters into a Definitive Agreement to Divest vitaCare to GoodRx
7:47am
8-K
e52rarsk69 1lkgl
3 Jan 22
Other Events
6:03am
8-K
14q3 1i8iixj3bo
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
cnljh
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
eli4klle7kz8ii
8 Dec 21
Regulation FD Disclosure
6:55am
8-K/A
EX-99.1
f87rv
16 Nov 21
Results of Operations and Financial Condition
6:30am